- Sections
- C - Chimie; métallurgie
- C07D - Composés hétérocycliques
- C07D 211/88 - Atomes d'oxygène liés en positions 2 et 6, p.ex. glutarimide
Détention brevets de la classe C07D 211/88
Brevets de cette classe: 125
Historique des publications depuis 10 ans
|
9
|
8
|
10
|
16
|
9
|
10
|
5
|
9
|
8
|
2
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Propriétaires principaux
| Proprétaire |
Total
|
Cette classe
|
|---|---|---|
| Cv6 Therapeutics (NI) Limited | 31 |
15 |
| Takeda Pharmaceutical Company Limited | 2961 |
6 |
| University of Southern California | 2016 |
6 |
| C4 Theraprutics, Inc. | 41 |
6 |
| California Institute of Technology | 3884 |
4 |
| Obschestvo S Ogranichennoi Otvetstvennostiyu "pharmenterprises" | 34 |
4 |
| Ranbaxy Laboratories Limited | 453 |
4 |
| Rhodia Operations | 1645 |
4 |
| Zhejiang Jiuzhou Pharmaceutical Co., Ltd. | 54 |
3 |
| Bioventures, LLC | 201 |
3 |
| Kymera Therapeutics, Inc. | 175 |
3 |
| Shuttle Pharmaceuticals, Inc. | 15 |
3 |
| Mitsui Chemicals Agro, Inc. | 93 |
2 |
| Council of Scientific & Industrial Research | 1397 |
2 |
| Eli Lilly and Company | 3645 |
2 |
| Institute of Zoology, Chinese Academy of Sciences | 98 |
2 |
| Keio University | 1053 |
2 |
| Mirati Therapeutics, Inc. | 199 |
2 |
| NHWA Pharma. Corporation | 52 |
2 |
| Tianjin Hemay Bio-Tech Co., Ltd. | 27 |
2 |
| Autres propriétaires | 48 |